abstract |
The present invention relates to a novel 4-pregenene-11-17-21-triol-3,20-dione derivative, a method for preparing the same, a pharmaceutical composition containing the same, and a medicament, as a modulator of a glucocorticoid or a mineralocorticoid receptor. To its use. The present invention relates in particular to the use of said compounds and pharmaceutical compositions thereof for the treatment of disorders related to glucocorticoid or mineralocorticoid receptor modulation. |